Liste des articles autour de la thrombose et du cancer des membres du GFTC
2020
-
-
- What is the current state of thrombosis treatment and prevention in cancer patients? Farge D. J Med Vasc. 2020 Nov;45(6S):6S1-6S2. doi: 10.1016/S2542-4513(20)30512-5.
- How to treat venous thromboembolism (TVE) in cancer patients: ten years of multidisciplinary team meetings (MDTM) at Saint-Louis Hospital. Crichi B, Sebuhyan M, Abdallah NA, Montlahuc C, Bonnet C, Villiers S, Maignan CL, Yannoutsos A, Farge D. J Med Vasc. 2020 Nov;45(6S):6S24-6S30.
- Drug-drug interaction (DDI) with direct oral anticoagulant (DOAC) in patients with cancer. Sebuhyan M, Crichi B, Abdallah NA, Bonnet C, Deville L, Marjanovic Z, Farge D. J Med Vasc. 2020 Nov;45(6S):6S31-6S38. doi: 10.1016/S2542-4513(20)30517-4. doi: 10.1016/S2542-4513(20)30516-2.
- Management of Cancer-Associated Thrombosis: An Evolving Area.Frere C, Connors JM, Farge D. Cancers (Basel). Cancers 2020, October; 12(10), 2999; oi.org/10.3390/cancers12082028
- Primary Thromboprophylaxis in Ambulatory Pancreatic Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frere C, Crichi B, Bournet B, Canivet C, AIt Abdallah N, Buscail L, Farge D. Cancers (Basel). Cancers 2020, July; 12(8), 2028; doi.org/10.3390/cancers12082028
- Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes. Frere C, Bournet B, Gourgou S, Fraisse J, Canivet C, Connors JM, Buscail L, Farge D; BACAP Consortium. Gastroenterology. 2020 Apr;158(5):1346-1358.e4. doi: 10.1053/j.gastro.2019.12.009.
- Primary prophylaxis of venous thromboembolism in extragonadal germ-cell tumour. Kubicek P, Boughalem E, Frere C. J Med Vasc. 2020 Apr;45(2):90-92. doi: 10.1016/j.jdmv.2020.01.152.
- Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented. Farge D, Bournet B, Conroy T, Vicaut E, Rak J, Zogoulous G, Barkun J, Ouaissi M, Buscail L, Frere C. Cancers (Basel). 2020 Mar 6;12(3). pii: E618. doi: 10.3390/cancers12030618.
- Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. Rafii H, Frere C, Benzidia I, Crichi B, Andre T, Assenta E, Bournet B, Carpentier A, Connault J, Doucet L, Durant C, Emmerich J, Gris JC, Hij A, Le Hello C, Madeleine I, Messas E, N(Dour A, Villiers S, Marjanovic Z, Ait Abdallah N, Yannoutsos A, Farge D. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC). J Med Vasc. 2020 Feb;45(1):28-40. doi: 10.1016/j.jdmv.2019.12.004
- New progress in the treatment and prophylaxis of venous thrombo-embolism in cancer patients. Connors JM, Farge D. J Med Vasc. 2020 Feb;45(1):2. doi: 10.1016/j.jdmv.2019.12.005
-
2019
-
-
- Antiplatelet Agents for Cancer Prevention: Current Evidences and Continuing Controversies. Frere C, Lejeune M, Kubicek P, Faille D, Marjanovic Z; and the Groupe Francophone Thrombose et Cancer. Cancers (Basel). 2019 Oct 24;11(11). pii: E1639. doi: 10.3390/cancers11111639.
- 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, Brenner B, Kakkar A, Rafii H, Solymoss S, Brilhante D, Monreal M, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2019 Lancet Oncol. 2019 Sep 3. pii: S1470-2045(19)30336-5. doi: 10.1016/S1470-2045(19)30336-5.
- Women, thrombosis, and cancer. Farge D, Le Maignan C, Doucet L, Frere C. Thromb Res. 2019 Sep;181 Suppl 1:S47-S53. doi: 10.1016/S0049-3848(19)30367-6.
- Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challenges. Farge D, Frere C. F1000 Research 2019, 8(F1000 Faculty Rev):974
- Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE database. Fuentes HE, Tafur AJ, Caprini JA, Alatri A, Trujillo-Santos J, Farge-Bancel D, Rosa V, Font L, Vilaseca A, Monreal M; RIETE Investigators. Int Angiol. 2019 May 16. doi: 10.23736/S0392-9590.19.04110-5
- Factors influencing patient’s perception of long-term treatment with low-molecular-weight heparins for cancer-associated thrombosis: an updated analysis of TROPIQUE, a prospective observational study. Debourdeau P, Arvers P, Hij A, Bennani H, Desauw C, Falvo N, Ghiringhelli F, Hamadé A, Vedrine L, Farge D. Support Care Cancer. 2019 May 1. doi: 10.1007/s00520-019-04815-z. [Epub ahead of print]
- Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges. Frere C, Benzidia I, Marjanovic Z, Farge D.Cancers (Basel). 2019 Jan 10;11(1). pii: E71. doi: 10.3390/cancers11010071.
- The best direct-acting oral anticoagulant for treatment of venous thromboembolism? Frere C, Farge D. Lancet Haematol. 2018 Dec 14. pii: S2352-3026(18)30211-4. doi: 10.1016/S2352-3026(18)30211-4.
-
2018
-
-
- Treatment of cancer associated thrombosis: Which role for direct oral anticoagulants in 2018? Frere C, Farge D. J Med Vasc. 2018 Sep;43(5):293-301.
- Edoxaban for Cancer-Associated Venous Thromboembolism. Frere C, Dufilho M. N Engl J Med. 2018 Jul 5;379(1):94. doi: 10.1056/NEJMc1806646.
- Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC). Farge D, Cajfinger F, Falvo N, Berremili T, Couturaud F, Bensaoula O, Védrine L, Bensalha H, Bonnet I, Péré-Vergé D, Coudurier M, Li V, Rafii H, Benzidia I, Connors JM,* and Resche-Rigon M. Oncotarget. 2018; 9:26990-26999.
- Clinical Course of Venous Thromboembolism in Patients with Pancreatic Cancer: Insights from the RIETE Registry. Frere C, Trujillo-Santos J, Font C, Sampériz Á, Quintavalla R, González-Martínez J, Vázquez FJ, Lima J, Farge D, Monreal M; RIETE Investigators. Thromb Haemost. 2018 Apr 21. doi: 10.1055/s-0038-1642009.
- Venous thromboembolism and pancreatic cancer. Frere C, Bournet B, Benzidia I, Jamelot M, Debourdeau P, Hij A, Rafii-Elayoubi A, Buscail L, Farge D, pour le Groupe francophone thrombose et cancer. J Med Vasc. 2018 In Press. doi: 10.1016/j.jdmv.2018.05.003
- Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism. Kuperman A, Lopez-Reyes R, Bosco LJ, Lorenzo A, Jose B, Farge-Bancel D, Alfonso M, Lumbierres M, Stemer G, Monreal Bosch M, Braester A; RIETE Investigators. J Thromb Thrombolysis. 2018 Jan 30. doi: 10.1007/s11239-018-1610-9.
- Risk of Arterial Thrombosis in Cancer Patients: Which Role for Cancer Therapies Vascular Toxicities? Frere C, Martin-Toutain I, Thuny F, Bonello L. J Am Coll Cardiol. 2018 Jan 16;71(2):260. doi: 10.1016/j.jacc.2017.10.087.
-
2017
-
-
- New international guidelines for curative treatment and prophylaxis for venous thromboembolism (VTE) in cancer patients and the dedicated smartphone application. Benzidia I, Connault J, Solanilla A, Michon-Pasturel U, Jamelot M, Nguessan MK, Hij A, Le Maignan C, Farge D, Frère C; pour le Groupe Francophone Thrombose et Cancer.. J Med Vasc. 2017 Dec;42(6):375-383. doi:10.1016/j.jdmv.2017.09.006
- Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study. Debourdeau P, Espié M, Chevret S, Gligorov J, Elias A, Dupré PF, Desseaux K, Kalidi I, Villiers S, Giachetti S, Frere C, Farge D. Cancer Med. 2017 Oct 4. doi: 10.1002/cam4.1201. [Epub ahead of print]
- Implementation of international good clinical practice guidelines to improve care of patients with cancer-related venous thromboembolism. Qari R, Frere C, Farge D, El Ayoubi H. Journal of Applied Hematology. 2017. 8; 42 (3) : 85-98.doi: 10.4103/joah.joah_32_17
- Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function. Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, Brekelmans MP, Büller HR, Elias A, Farge D, Konstantinides S, Palareti G, Prandoni P, Righini M, Torbicki A, Vlachopoulos C, Brodmann M.Eur Heart J. 2017 Feb 17. doi: 10.1093/eurheartj/ehx003.
- Women, thrombosis, and cancer: A gender-specific analysis. Farge D, Bounameaux H, Bauersachs RM, Brenner B. Thromb Res. 2017 Mar;151 Suppl 1:S21-S29. doi: 10.1016/S0049-3848(17)30062-2.
- Analysis of clinical factors affecting the rates of fatal pulmonary embolism and bleeding in cancer patients with venous thromboembolism. Trujillo-Santos J, Martos FM, Font C, Farge-Bancel D, Rosa V, Lorenzo A, Barrón M, Lorente MA, Pedrajas JM, Monreal M. Heliyon. 2017 Jan 16;3(1):e00229. doi: 10.1016/j.heliyon.2016.e00229.
-
2016
-
-
- Maladie thromboembolique veineuse et cancer : recommandations internationales pour le traitement curatif et préventif
C. FRERE a, P. DEBOURDEAU b, M. MARTYc, E. MARJANOVIC d , F. CAJFINGER e, D. FARGE f pour le Groupe francophone Thrombose et cancer. a : CHU Timone ; b : Institut Sainte-Catherine, Avignon ; c : Hôpital Saint-Louis, Paris ; d : Hôpital Saint-Antoine, P
Cardiologie-Pratique.com, 27 SEP 2016. - International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge, Henri Bounameaux, Benjamin Brenner, Francis Cajfinger, Philippe Debourdeau, Alok A Khorana, Ingrid Pabinger, Susan Solymoss, James Douketis, Ajay Kakkar
Lancet 0ncology October 2016 ; 27 :10 - Major bleeding complications in patients treated with direct oral anticoagulants: One-year observational study in a Paris Hospital
L. Deville, M. Konan, A. Hij, L. Goldwirt, O. Peyrony, F. Fieux, P. Faure, I. Madelaine, S. Villiers, D. Farge-Bancel, C. Frère
Current Research in Translational Medicine, 64 (2016) 129–133 - Clinical practice guidelines for prophylaxis of venous thomboembolism in cancer patients.
Frere C, Farge D.
Thromb Haemost. 2016 Sep 27;116(4):618-25. doi: 10.1160/TH16-04-0302. Epub 2016 Aug 25. - Low-molecular-weight heparins for cancer-associated thrombosis: Adherence to clinical practice guidelines and patient perception in TROPIQUE, a 409-patient prospective observational study.
Cajfinger F, Debourdeau P, Lamblin A, Benatar V, Falvo N, Benhamou Y, Sevestre MA, Farge-Bancel D; TROPIQUE investigators.
Thromb Res. 2016 Aug;144:85-92. doi: 10.1016/j.thro - Prophylaxis of venous thromboembolism in cancer patients.Frere C, Doucet L, Farge D.Expert Rev Hematol. 2016 Jun;9(6):535-9. doi:
10.1586/17474086.2016.1172959. Epub 2016 May 3.
PMID:27031534 - Role of platelets in cancer and cancer-associated thrombosis:.Experimental and clinical evidences
Mezouar S, Frère C, Darbousset R, Mege D, Crescence L, Dignat-George F, Panicot-Dubois L, Dubois C.
Thromb Res. 2016 Mar;139:65-76. - Microparticles and cancer thrombosis in animal models.
Mege D, Mezouar S, Dignat-George F, Panicot-Dubois L, Dubois C. Thromb Res. 2016 Apr;140 Suppl 1:S21-6. - Low-molecular-weight heparins for cancer-associated thrombosis: Adherence to clinical practice guidelines and patient perception in TROPIQUE, a 409-patient prospective observational study.
Cajfinger F, Debourdeau P, Lamblin A, Benatar V, Falvo N, Benhamou Y, Sevestre MA, Farge-Bancel D for TROPIQUE investigators
T hromb Res. 2016;144:85-92. - ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
Pepin M, Kleinjan A, Hajage D, Büller HR, Di Nisio M, Kamphuisen PW, Salomon L, Veyradier A, Stepanian A, Mahe I.
J Thromb Haemost. 2016 Feb;14(2):306-15. doi: 10.1111/jth.13205. Epub 2016 Jan 25. - The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study.
Mege D, Panicot-Dubois L, Ouaissi M, Robert S, Sielezneff I, Sastre B, Dignat-George F, Dubois C.
Int J Cancer. 2016 Feb 15;138(4):939-48. doi: 10.1002/ijc.29837. Epub 2015 Oct 1.
- Maladie thromboembolique veineuse et cancer : recommandations internationales pour le traitement curatif et préventif
-
2015
-
-
- Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
Farge D, Trujillo-Santos J, Debourdeau P, Bura-Riviere A, Rodriguez-Beltrán EM, Nieto JA, Peris ML, Zeltser D, Mazzolai L, Hij A, Monreal M; RIETE Investigators.
Medicine (Baltimore). 2015 Aug;94. - Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
Farge D, Trujillo-Santos J, Debourdeau P, Bura-Riviere A, Rodriguez-Beltrán EM, Nieto JA, Peris ML, Zeltser D, Mazzolai L, Hij A, Monreal M; RIETE Investigators.
Medicine (Baltimore). 2015 Aug;94(32):e1235. doi:10.1097/MD.0000000000001235. - Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma.
Ouaissi M, Frasconi C, Mege D, Panicot-Dubois L, Boiron L, Dahan L, Debourdeau P, Dubois C, Farge D, Sielezneff I.
Hepatobiliary Pancreat Dis Int. 2015 Aug;14(4):436-42. - Thrombosis, Aging and Cancer : Pathophysiology.
Frere C, Panicot-Dubois L, Nguessan M, Dubois C.
Journal d’oncogériatrie 2015. Volume 5 n°3. - Thrombose et cancer, une association fréquente et de mauvais prognostic.
Frere C, Hij A, Debourdeau P, Cajfinger F, Villiers S, Marcy PY, Dubois C, Farge D. Cardiologie et Nutrition 2015 ; Hors-série n°6 :137-139. - Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo.
Mezouar S1, Darbousset R, Dignat-George F, Panicot-Dubois L, Dubois C. Int. J. Cancer. 2015; Jan 15;136(2):462-75. - Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice.
ThomasGM, Brill A, Mezouar S, Crescence L, Gallant M, Dubois C, Wagner DD. J Thromb Haemost. 2015 Jul;13:1310-9.
- Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
-
2014
-
-
- Involvement of platelet-derived microparticles in tumor progression and thrombosis.
Mezouar S, Mege D, Darbousset R, Farge D, Debourdeau P, Dignat-George F, Panicot-Dubois L, Dubois C.
Semin Oncol. 2014 Jun;41(3):346-58. doi: 10.1053/j.seminoncol.2014.04.010. - Implementing thrombosis guidelines in cancer patients: a review.
Farge-Bancel D, Bounameaux H, Brenner B, Büller HR, Kakkar A, Pabinger I, Streiff M, Debourdeau P.
Rambam Maimonides Med J. 2014 Oct 29;5(4):e0041. doi: 10.5041/RMMJ.10175. - Therapy for cancer-related thromboembolism.
Frere C, Debourdeau P, Hij A, Cajfinger F, N’Guessan M, Panicot-Dubois L, Dubois C, Farge D.
Semin Oncol. 2014 Jun;41(3):319-38. doi: 0.1053/j.seminoncol.2014.04.005. - Anticancéreux : utilisation pratique (7ème édition) : La maladie Thromboembolique veineuse. Prévention des événements indésirables.
Deville L, Debourdeau P, Farge D.
Editions CNHIM. - Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study.
Sevestre MA, Belizna C, Durant C, Bosson JL, Vedrine L, Cajfinger F,Debourdeau P, Farge D; Carmen Investigators for the Groupe Francophone Thrombose et Cancer (GFTC).
J Mal Vasc. 2014 May;39(3):161-8. doi: 10.1016/j.jmv.2014.03.001. Epub 2014 Apr 18. - The Subcommittee on Haemostasis Malignancy.Prevention of VTE in Cancer Outpatients: guidance from the SSC of the ISTH
Khorana AA, Otten HM, Zwicker JI, Connolly GC, Farge-Bancel D, Pabinger I; J Thromb Haemost. 2014;12:1928-31
- Involvement of platelet-derived microparticles in tumor progression and thrombosis.
-
2013
-
-
- Venous thromboembolism prophylaxis in patients undergoing abdominal or pelvic surgery for cancer–a real-world, prospective, observational French study: PRéOBS.
Samama CM, Boubli L, Coloby P, Debourdeau P, Gruel Y, Mariette C, Mottier D,
Rischmann P, Toubiana L, Steib A.
Thromb Res. 2014 Jun;133(6):985-92. doi: 10.1016/j.thromres.2013.10.038. Epub 2013 Nov 1. - International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer.
Debourdeau P, Farge D, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Büller HR, Bounameaux H. .
J Thromb Haemost. 2013 Jan;11(1):71-80. doi: 10.1111/jth.12071.PMID: 23217208 - International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR..
J Thromb Haemost. 2013 Jan;11(1):56-70. doi: 10.1111/jth.12070
- Venous thromboembolism prophylaxis in patients undergoing abdominal or pelvic surgery for cancer–a real-world, prospective, observational French study: PRéOBS.
-
2011
-
-
- Fever and deep venous thrombosis. Findings from the RIETE registry.
Barba R, Di Micco P, Blanco-Molina A, Delgado C, Cisneros E, Villalta J, Morales MV, Bura-Riviere A, Debourdeau P, Monreal M.
J Thromb Thrombolysis. 2011 Oct;32(3):288-92. doi: 10.1007/s11239-011-0604-7. - How to improve the implementation of guidelines on cancer-related thrombosis.
Debourdeau P, Beckers M, Gérôme P, Durant C, Lacoin Q, Debourdeau A, Bancel DF.
Expert Rev Anticancer Ther. 2011 Mar;11(3):473-83. Review.PMID:21417859
Voir l’article/ PDF
- Fever and deep venous thrombosis. Findings from the RIETE registry.
-
-
-
- [Guidelines for good clinical practice: prevention and treatment of venous
thromboembolism in medical patients].
Mismetti P, Baud JM, Becker F, Belmahdi F, Blanchard P, Constans J, Couturaud
F, Debourdeau P, Drouet L, Dumarcet N, Ferrari E, Galanaud JP, Girard P, Hay B,
Laporte S, Laroche JP, Leizorovicz A, Liard F, Mahé I, Meyer G, Oger E, Parent F,
Quéré I, Samama M; Agence française de sécurité sanitaire des produits de santé.
J Mal Vasc. 2010 Jun;35(3):127-36. doi:10.1016/j.jmv.2009.12.002. Epub 2010 Feb 16. French. - 2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group.
Farge D, Bosquet L, Kassab-Chahmi D, Mismetti P, Elalamy I, Meyer G, Cajfinger F, Desmurs-Clavel H, Elias A, Grange C, Hocini H, Legal G, Mahe I, Quéré I, Levesque H, Debourdeau P; SOR.
Crit Rev Oncol Hematol. 2010 Jan;73(1):31-46. - Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
Farge D, Durant C, Villiers S, Long A, Mahr A, Marty M, Debourdeau P; Groupe Francophone Thrombose et Cancer (GFTC).
Thromb Res. 2010r;125 Suppl 2:S108-16.
- [Guidelines for good clinical practice: prevention and treatment of venous
-
2009
-
-
- Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action
Alok A. Khorana, Michael B. Streiff, Dominique Farge, Mario Mandala, Philippe Debourdeau,Francis Cajfinger, Michel Marty, Anna Falanga, and Gary H. Lyman
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799060/ - 2008 SOR* French guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: Report from the working group
Debourdeau P, Kassab Chahmi D, Bosquet L, Legal G, Kriegel I, Desruennes E, Douard MC, Elalamy I, Meyer G, Mismetti P, Pavic M, Renaudin JM, Scrobohacci ML, Lévesque H, Quéré I, Farge D.
Ann Oncol. 2009 Sep;20(9):1459-71 - Traitement curatif de la maladie thromboembolique veineuse, prévention et traitement des thromboses veineuses sur cathéter chez les patients atteints de cancer.
Elias A, Debourdeau P, Renaudin JM, Desmurs-Clavel H, Mahé I, Elalamy I, Pavic M, Kassab-Chahmi D, Bosquet L, Cajfinger F, Desruennes E, Douard MC, Grange C, Hocini H, Kriegel I, Le Gal G, Meyer G, Mismetti P, Quéré I, Scrobohaci ML, Lévesque H, Farge-Bancel D.
Presse médicale :2009 Feb; 38(2): 220-230. - Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action.
Khorana AA, Streiff MB, Farge D, Mandala M, Debourdeau P, Cajfinger F, Marty M, Falanga A, Lyman GH.
J Clin Oncol. 2009;27:4919-26
- Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action
-
2008
-
-
- Thromboses sur cathéter central chez le patient cancéreux.
Debourdeau P, Chahmi DK, Zammit C, Farge-Bancel D.
Pathol Biol (Paris). 2008 Jun;56(4):211-9. - Traitement de la maladie thromboembolique veineuse chez le cancéreux.
D. Farge-Bancel, L. Florea, L. Bosquet, P. Debourdeau.
Pathol Biol (Paris). 2008 Jun;56(4):220-8. - Long-term use of daily subcutaneous low molecular weight heparin in cancer patients with venous thromboembolism: why hesitate any longer?
Debourdeau P, Elalamy I, de Raignac A, Meria P, Gornet JM, Amah Y, Korte W, Marty M, Farge D.
Support Care Cancer. 2008 Dec;16(12):1333-41.
Article en PDF/
- Thromboses sur cathéter central chez le patient cancéreux.
-
-
-
-
Les SOR: Standards, Options, Recommandations 2008
SOR2008: Cliquez pour télécharger THROMBOSE ET CANCER
Contexte et objectifs
La mise en place d’un groupe d’experts chargés d’établir des recommandations nationales, sur la prise en charge de la maladie thromboembolique en cancérologie, a été motivée par les éléments suivants :
l’évolution des connaissances sur la thromboseveineuse et son impact pronostique ;
les disparités constatées dans la pratique clinique ;
la modification des pratiques et l’absence de référentiels nationaux ;
l’augmentation prévisible des thromboses sur cathéterliée, d’une part à l’augmentation des cancers, et d’autre part à la généralisation des poses de cathéters,
notamment avec chambres implantables.
L’objectif de ces Recommandations est de définir, sur la base d’une analyse critique des données actuelles de la science et de l’accord d’experts,
le traitement curatif dela maladie thromboembolique veineuse ainsi que la prévention et le traitement des thromboses veineuses
sur cathéter chez les patients atteints de cancer.
Ces Recommandations s’adressent aux cliniciens concernés par la prise en charge des personnes atteintes
de cancer et impliqués dans la prise en charge de la maladie thromboembolique veineuse.
Les Recommandations SOR ne se substituent pas au jugement clinique des médecins. -
Autour des SOR…
-
-
[CAJFINGER2008] Cajfinger F, Hocini H, Pavic M, Desmurs-Clavel H, Desruennes E, Douard MC, Bosquet L, Kriegel I, Debourdeau P, Elalamy I, Elias A, Grange C, Kassab-Chahmi D, Le Gal G., Levesque H, Mahe I, Mismetti P, Quere I, Renaudin JM, Scrobohaci ML, Meyer G, Farge-Bancel D. Standards, Options : Recommandations 2008 Traitement curatif de la maladie thromboembolique veineuse chez les patients atteints de cancer. Sang Thrombose Vaisseaux 2008;20(8):411-20.
Download (PDF, 364KB)
(2) [DEBOURDEAU2008] Debourdeau P, Farge-Bancel D, Bosquet L, Kassab-Chahmi D, Cajfinger F, Desmurs-Clavel H, Desruennes E, Douard MC, Elias A, Elalamy I, Grange C, Hocini H, Kriegel I, Le Gal G., Levesque H, Mahe I, Meyer G, Mismetti P, Pavic M, Quere I, Renaudin JM, Scrobohaci ML. Standards, Options : Recommandations 2008. Traitement curatif de la maladie thromboembolique veineuse, prevention et traitement des thromboses veineuses sur catheter chez les patients atteints de cancer. [2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients]. Bull Cancer 2008;95(7):750-61.
Abstract: The <<Standards, Options : Recommendations>> (SOR) project has been undertaken by the French National Federation of Cancer Centers (FNCLCC) is now part of the French National Cancer Institute. The project involves the development and updating of evidence-based Clinical Practice Guidelines (CPG) in oncology. In order to answer questions related to venous thromboembolic events (VTE) treatment and to central venous catheter thrombosis (CVCT) management in cancer patients, the SOR elaborated national guidelines, here presented in a short report. It results of a collaborative work with members from three learned societies (“societe nationale francaise de medicine interne”: SNFMI, “societe francaise de medicine vasculaire”: SFMV and “societe francaise d’anesthesie-reanimation”: SFAR)
(3) [DEBOURDEAU2008A] Debourdeau P, Desmurs-Clavel H, Pavic M, Quere I, Kriegel I, Desruennes E, Douard MC, Kassab-Chahmi D, Bosquet L, Cajfinger F, Elalamy I, Grange C, Hocini H, Levesque H, Mahe I, Meyer G, Mismetti P, Renaudin JM, Scrobohaci ML, Elias A, Le Gal G., Farge-Bancel D. Standards, Options : Recommandations 2008 Prévention et traitement des thromboses veineuses sur cathéter chez les patients atteints de cancer. Revue de Médecine Interne 2008;29(Décembre):1058-67.
Download (PDF, 323KB)
(4) [DEBOURDEAU2008B] Debourdeau P, Farge-Bancel D, Bosquet L, Kassab-Chahmi D, Cajfinger F, Desmurs-Clavel H, Desruennes E, Douard MC, Elias A, Elalamy I, Grange C, Hocini H, Kriegel I,
Download (PDF, 112KB)
Le Gal G., Levesque H, Mahe I, Meyer G, Mismetti P, Pavic M, Quere I, Renaudin JM, Scrobohaci ML. Recommandations pour la pratique clinique 2008 : Prise en charge de la thrombose veineuse chez les patients atteints de cancer (méthode SOR). Oncologie 2008;12(Décembre):Sous presse.
(5) [DEBOURDEAU2009] Debourdeau P, Kassab-Chahmi D, Bosquet L, Cajfinger F, Desmurs-Clavel H, Desruennes E, Douard MC, Elias A, Elalamy I, Grange C, Hocini H, Kriegel I, Le Gal G., Levesque H, Mahe I, Meyer G, Mismetti P, Pavic M, Quere I, Renaudin JM, Scrobohaci ML, Farge-Bancel D. Standards, Options : Recommandations 2008. Prévention et traitement des thromboses veineuses sur cathéter chez les patients atteints de cancer. Médecine thérapeutique 2009;In Press.
(6) [DEBOURDEAU2009A] Debourdeau P, Kassab-Chahmi D, Bosquet L, Le Gal G., Kriegel I, Desruennes E, Douard MC, Elalamy I, Meyer G, Mismetti P, Pavic M, Scrobohaci ML, Levesque H, Renaudin JM, Farge-Bancel D. 2008 SOR French guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: Report from the working group.
Download (PDF, 123KB)
(7) [ELALAMY2008] Elalamy I, Mismetti P, Scrobohaci ML, Douard MC, Grange C, Desruennes E, Kassab-Chahmi D, Le Gal G., Bosquet L, Cajfinger F, Desmurs-Clavel H, Elias A, Farge-Bancel D, Hocini H, Kriegel I, Levesque H, Mahe I, Meyer G, Pavic M, Quere I, Renaudin JM, Debourdeau P. Standards, Options : Recommandations 2008. Prévention et traitement des thromboses veineuses sur cathéter chez les patients atteints de cancer. Sang Thrombose Vaisseaux 2008;20(8):422-9.
Download (PDF, 342KB)
(8) [ELIAS2009] Elias A, Debourdeau P, Renaudin JM, Desmurs-Clavel H, Mahe I, Elalamy I, Pavic M, Kassab-Chahmi D, Bosquet L, Cajfinger F, Desruennes E, Douard MC, Grange C, Hocini H, Kriegel I, Le Gal G., Meyer G, Mismetti P, Quere I, Scrobohaci ML, Levesque H, Farge-Bancel D. Standards, Options : Recommandations 2008 Traitement curatif de la maladie thromboembolique veineuse, prévention et traitement des thromboses veineuses sur cathéter chez les patients atteints de cancer. Presse médicale 2009;38:220-30.
Download (PDF, 385KB)
(9) [FARGEBANCEL2008] Farge-Bancel D, Scrobohaci ML, Debourdeau P, Le Gal G., Elias A, Levesque H, Grange C, Bosquet L, Desmurs-Clavel H, Desruennes E, Douard MC, Elalamy I, Hocini H, Kassab-Chahmi D, Kriegel I, Mahe I, Meyer G, Pavic M, Quere I, Renaudin JM, Cajfinger F, Mismetti P. Standards, Options : Recommandations 2008 Traitement curatif de la maladie thromboembolique veineuse, prévention et traitement des thromboses veineuses sur cathéter chez les patients atteints de cancer. Hématologie 2008;14(4):1-16.
Download (PDF, 480KB)
(10) [FARGEBANCEL2008A] Farge-Bancel D, Mismetti P, Grange C, Elalamy I, Mahe I, Hocini H, Quere I, Bosquet L, Debourdeau P, Desmurs-Clavel H, Desruennes E, Douard MC, Elias A, Kassab-Chahmi D, Kriegel I, Le Gal G., Meyer G, Pavic M, Renaudin JM, Scrobohaci ML, Cajfinger F, Levesque H. Standards, Options : Recommandations 2008 Traitement curatif de la maladie thromboembolique veineuse chez les patients atteints de cancer. Revue de Médecine Interne 2008;29(Décembre):1068-79.
Download (PDF, 333KB)
(11) [FARGEBANCEL2009] Farge-Bancel D, Bosquet L, Kassab-Chahmi D, Cajfinger F, Desmurs-Clavel H, Desruennes E, Douard MC, Elias A, Elalamy I, Grange C, Hocini H, Kriegel I, Le Gal G., Levesque H, Mahe I, Meyer G, Mismetti P, Pavic M, Quere I, Renaudin JM, Scrobohaci ML, Debourdeau P. Standards, Options : Recommandations 2008. Traitement curatif de la maladie thromboembolique veineuse chez les patients atteints de cancer. Médecine thérapeutique 2009;In Press.
(12) [FARGEBANCEL2009A] Farge-Bancel D, Bosquet L, Kassab-Chahmi D, Mismetti P, Elalamy I, Meyer G, Cajfinger F, Desmurs-Clavel H, Elias A, Grange C, Hocini H, Le Gal G., Mahe I, Quere I, Levesque H, Debourdeau P. 2008 SOR guidelines for the treatment of venous thromboembolism in patients with cancer: Report from the working group. Critical Review in Oncology/Hematology 2009;In Press.
Download (PDF, 513KB)
(13) [KRIEGEL2008] Kriegel I, Desruennes E, Douard MC, Grange C, Renaudin JM, Meyer G, Scrobohaci ML, Kassab-Chahmi D, Bosquet L, Cajfinger F, Desmurs-Clavel H, Elias A, Elalamy I, Farge-Bancel D, Hocini H, Levesque H, Mahe I, Mismetti P, Pavic M, Quere I, Le Gal G., Debourdeau P. Standards, Options: recommandations 2008; traitement curatif de la maladie thromboembolique veineuse, prevention et traitement des thromboses veineuses sur catheter chez les patients atteints de cancer. [Standards, Options: recommendations 2008; thromboembolic events treatment, prophylaxis and treatment of central venous catheter thrombosis in patients with cancer]. Ann Fr Anesth Reanim 2008;27(6):521-33.
(14) [MAHE2008] Mahe I, Elalamy I, Farge-Bancel D, Mismetti P, Scrobohaci ML, Hocini H, Meyer G, Kassab-Chahmi D, Bosquet L, Cajfinger F, Desmurs-Clavel H, Desruennes E, Douard MC, Elias A, Grange C, Kriegel I, Le Gal G., Levesque H, Pavic M, Renaudin JM, Debourdeau P, Quere I. Standards, Options : Recommandations 2008 Traitement curatif de la maladie thromboembolique veineuse, prévention et traitement des thromboses veineuses sur cathéter chez les patients atteints de cancer. Journal des maladies vasculaires 2008;33(3):140-54.
Download (PDF, 2MB)
2007
- Cancer Occulte et embolie pulmonaire : Embolie Pulmonaire.
P Debourdeau, D Farge.
La revue du Praticien vol. 57, n° 7, 2007, pages 737-742. - Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.
Debourdeau P, Zammit C, Pavic M , Bensaid, Farge-Bancel D.
Rev Med Interne. 2007 Jul;28(7):471-483. - Numéro spécial PATHOLOGIE BIOLOGIE Vol 56 – N° 4 – juin 2008 / PP. 177-250
2006
- Cancer occulte et maladie thromboembolique veineuse/Occult cancer and venous thromboembolism.
H. Lévesque - Venous thromboembolism and cancer.
M Pavic, P Debourdeau, M Aletti, D Farge, H Rousset.
La Revue de Médecine Interne 2006 ; 27 (4) : 313-322.
2004
-
-
- [Cardiac prevention: the oncologic point of view].
Gligorov J, Debourdeau P, Arsovski O, Lotz JP.
Bull Cancer. 2004 Nov;91 Suppl 3:192-200. - [Cardiotoxicity of 5-fluorouracil].
Teixeira L, Barry S, Debourdeau P, Cohen A, Tournigand C.
Bull Cancer. 2004 Nov;91 Suppl 3:154-8. Review. French. PubMed - [Malignant cardiac tumors].
Debourdeau P, Gligorov J, Teixeira L, Aletti M, Zammit C.
Bull Cancer. 2004 Nov;91 Suppl 3:136-46. Review. French. PubMed
- [Cardiac prevention: the oncologic point of view].
-
2002
-
-
- CANTHANOX, a randomised controlled study comparing low molecular weight heparin and warfarin for the long term treatment of venous thromboembolism in patients with cancer.
G. Meyer, Z. Marjanovic, J. Valcke, B. Lorcerie, Y. Gruel, P. Solal-Celigny, C. Lemaignan, J.M. Extra, P. Cottu, D. Farge.
Archives of Internal Medicine 2002; 162:1729-173
- CANTHANOX, a randomised controlled study comparing low molecular weight heparin and warfarin for the long term treatment of venous thromboembolism in patients with cancer.
-
2000
-
-
- Maladie thromboembolique veineuse et cancer.
Sauve C, Boffa MC, Meyer G, Farge-Bancel D.
Revue de Médecine Interne 2000 ; 21(3) : 266-277.
- Maladie thromboembolique veineuse et cancer.
-
2000
-
-
- Traitement anticoagulant classique de la maladie thromboembolique chez les patients cancéreux : à propos d’un série rétrospective de 71 patients.
Debourdeau P, Farge D, Meyer G, Sayeg Z, Marjanovic Z, Bastit L, Cabane J, Merrer J, Extra JM
Rev. Méd. Interne 1996 ; 17 : 207-212
- Traitement anticoagulant classique de la maladie thromboembolique chez les patients cancéreux : à propos d’un série rétrospective de 71 patients.
-
1996
-
-
- Traitement anticoagulant classique de la maladie thromboembolique chez les patients cancéreux : à propos d’un série rétrospective de 71 patients.
Debourdeau P, Farge D, Meyer G, Sayeg Z, Marjanovic Z, Bastit L, Cabane J, Merrer J, Extra JM
Rev. Méd. Interne 1996 ; 17 : 207-212
- Traitement anticoagulant classique de la maladie thromboembolique chez les patients cancéreux : à propos d’un série rétrospective de 71 patients.
-